KNOW YOUR CLL Check-In

GET SPECIFIC ABOUT YOUR CLL

Answer some questions about your specific CLL signs, symptoms, tests, and genetic markers. Knowing these specifics along with your treatment history and physical health may help you better understand your CLL and potential treatment options.1,2

CKK Checklist

When you’re finished, you’ll receive the Know Your CLL Check-in Summary, which includes your genetic markers, plus useful information about CLL specifics. You can use this resource to prepare for your next doctor visit and guide the conversation about your CLL.

Start now >
Diagnosis report

References
1. Referenced with permission from the NCCN Guidelines for Patients®: Chronic Lymphocytic Leukemia V.2019. © NCCN Foundation®. 2019. All rights reserved. Accessed May 1, 2019. To view the most recent and complete version of the guideline, go online to NCCN.org/patients. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. 2. The Leukemia and Lymphoma Society. Chronic Lymphocytic Leukemia. White Plains, NY: The Leukemia and Lymphoma Society; 2014. Publication No. PS34 40M.

< BACK

Reference
1. Referenced with permission from the NCCN Guidelines for Patients®: Chronic Lymphocytic Leukemia V.2019. © NCCN Foundation®. 2019. All rights reserved. Accessed May 1, 2019. To view the most recent and complete version of the guideline, go online to NCCN.org/patients. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

Reference
1. The Leukemia and Lymphoma Society. Chronic Lymphocytic Leukemia. White Plains, NY: The Leukemia and Lymphoma Society; 2014. Publication No. PS34 40M.

References
1. Vernooij R, Willson M, et al. Characterizing patient-oriented tools that could be packaged with guidelines to promote self-management and guideline adoption: a meta-review. Implement Sci. 2016;11(52): doi: 10.1186/s13012-016-0419-1. 2. The Leukemia and Lymphoma Society. Chronic Lymphocytic Leukemia. White Plains, NY: The Leukemia and Lymphoma Society; 2017. Publication No. PS48 25M.

References
1. Referenced with permission from the NCCN Guidelines for Patients®: Chronic Lymphocytic Leukemia V.2019. © NCCN Foundation®. 2019. All rights reserved. Accessed May 1, 2019. To view the most recent and complete version of the guideline, go online to NCCN.org/patients. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. 2. The Leukemia and Lymphoma Society. Chronic Lymphocytic Leukemia. White Plains, NY: The Leukemia and Lymphoma Society; 2014. Publication No. PS34 40M.

References
1. Referenced with permission from the NCCN Guidelines for Patients®: Chronic Lymphocytic Leukemia V.2019. © NCCN Foundation®. 2019. All rights reserved. Accessed May 1, 2019. To view the most recent and complete version of the guideline, go online to NCCN.org/patients. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. 2. The Leukemia and Lymphoma Society. Chronic Lymphocytic Leukemia. White Plains, NY: The Leukemia and Lymphoma Society; 2014. Publication No. PS34 40M. 3. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma V.5.2019. © National Comprehensive Cancer Network, Inc. 2019. All rights reserved. Accessed May 23, 2019. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

References
1. Referenced with permission from the NCCN Guidelines for Patients®: Chronic Lymphocytic Leukemia V.2019. © NCCN Foundation®. 2019. All rights reserved. Accessed May 1, 2019. To view the most recent and complete version of the guideline, go online to NCCN.org/patients. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. 2. The Leukemia and Lymphoma Society. Chronic Lymphocytic Leukemia. White Plains, NY: The Leukemia and Lymphoma Society; 2014. Publication No. PS34 40M. 3. Hallek M, Cheson BD, Catovsky D, et al. CLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131(25): 2746-2760.

References
1. Referenced with permission from the NCCN Guidelines for Patients®: Chronic Lymphocytic Leukemia V.2019. © NCCN Foundation®. 2019. All rights reserved. Accessed May 1, 2019. To view the most recent and complete version of the guideline, go online to NCCN.org/patients. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. 2. The Leukemia and Lymphoma Society. Chronic Lymphocytic Leukemia. White Plains, NY: The Leukemia and Lymphoma Society; 2014. Publication No. PS34 40M.

References
1. IOM (Institute of Medicine). 2013. Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington, DC: The National Academies Press. 2. American Cancer Society. Talking with Your Doctor. American Cancer Society website. https://www.cancer.org/content/dam/cancer-org/cancer-control/en/booklets-flyers/talking-with-your-doctor-english-pdf.pdf. Updated November 17, 2015. Accessed October 10, 2018.

References
1. IOM (Institute of Medicine). 2013. Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington, DC: The National Academies Press. 2. The Leukemia and Lymphoma Society. Chronic Lymphocytic Leukemia. White Plains, NY: The Leukemia and Lymphoma Society; 2014. Publication No. PS34 40M. 3. American Cancer Society. Talking with Your Doctor. American Cancer Society website. https://www.cancer.org/content/dam/cancer-org/cancer-control/en/booklets-flyers/talking-with-your-doctor-english-pdf.pdf. Updated November 17, 2015. Accessed October 10, 2018.

Blood tests, like a complete blood count (CBC), can help you and your doctor better understand your CLL. When you discuss your CBC results with your doctor, you may hear the measures listed below.1

Which of the following measures do you track with your doctor? Check all that apply.

In CLL, changes to chromosomes and genes are common. Knowing your CLL genetic markers may help you and your doctor understand how your CLL may progress and develop a treatment plan.1,2

Has your doctor tested your CLL for any specific genetic markers (ie, changes to chromosomes or genes)?

Has your doctor talked to you about which treatment options, including oral nonchemotherapy options, may be appropriate for you?

Download diagnosis

Save this to your computer or tap the button below to save to your mobile device. 

You Finished!

Now it’s time to get the Know Your CLL Check-in Summary to help you learn more about CLL specifics, prepare for your next doctor visit, and guide the conversation about managing your CLL.

You Finished!

Now it’s time to get the Know Your CLL Check-in Summary to help you learn more about CLL specifics, prepare for your next doctor visit, and guide the conversation about managing your CLL.

By submitting an email address, you are requesting that this website contacts the following person you specify here on your behalf. Your name, contact information, and the intended recipient’s contact information are required. However, the information provided will be used for the sole purpose of sending requested communication. No information provided will be maintained or further used by this site.

Please see our privacy policy to learn more.

You Finished!

Now it’s time to get the Know Your CLL Check-in Summary to help you learn more about CLL specifics, prepare for your next doctor visit, and guide the conversation about managing your CLL.

Thank you! We have received your request.

Keep Learning About CLL >